Post-Victory Blues: Is the "Trump Trade" Starting to Backfire?

Deep News
Yesterday

Investors who rode the wave of Trump administration equity stakes in public companies have enjoyed substantial gains over the past year. However, with the midterm elections approaching and Democrats potentially reclaiming control of at least one chamber of Congress, this government-backed stock surge now faces multiple headwinds—litigation, congressional hearings, and political backlash could all reverse the rally in these politically favored equities.

According to an August 29 report, recent polls indicate rising Democratic odds, and market strategists are warning that a Democratic takeover of the Senate or House would trigger a wave of congressional investigations into government-held companies, threatening both corporate brands and stock valuations. Simultaneously, a shareholder lawsuit is challenging the legality of the government's equity stake in Intel (ASX: INTC)—if the court rules that the CHIPS Act does not authorize the Commerce Department to exchange subsidies for equity, the legal foundation of the entire government shareholding portfolio could be shaken.

Market strategists point out that much of the stock price appreciation came from short-lived bursts following announcements, followed by significant pullbacks, indicating that the momentum from government backing is inherently fragile. Henrietta Treyz, co-founder of research firm Veda Partners, stated that Democratic-led committees summoning corporate executives and government officials for testimony "is one of the key risks investors need to monitor right now."

A Government Investment Wave: Impressive Gains, but Mostly Fleeting

The Trump administration has pursued an unprecedented strategy: using government funds to acquire equity in listed companies, injecting state capital directly into the private sector. This approach quickly ignited market enthusiasm, with retail and institutional investors rushing to bet on the next "government-selected" target.

The headline numbers are striking. INTEL-T shares have surged more than 300% since reports of the Trump administration's investment talks first emerged last year; MP Materials has climbed 87% since the Defense Department invested $400 million in July; and Trilogy Metals has risen 73% since the U.S. government agreed to acquire a 10% stake last October.

However, the structure of these gains warrants caution. Trilogy Metals' U.S. shares spiked from $2.09 to a high of $10.60 within days of the deal announcement, then rapidly retreated to their current level of $3.62. MP Materials soared over 150% in the five weeks following the government's investment, but has since fallen nearly 27% over the past year. Intel peaked in June after Trump announced Apple would partner with the company to design and produce semiconductors, but has since dropped 37%, making it one of the worst-performing stocks in the S&P 500 during that period.

Aniket Shah, Jefferies' global head of Washington, sustainability, and transition strategy, attributes this rally to a simple logic: "You now have a government client and endorser, and the market believes it will make your company successful." Yet, the durability of this logic is increasingly being called into question.

Election Risk: If Democrats Flip Congress, Hearing Rooms Become the New Battlefield

The midterm elections represent the most immediate political risk hanging over these stocks. Polls suggest Democrats are favored to win a majority in at least one chamber of Congress, and once they secure committee chairmanships, the investigative machinery will spring into action.

Democratic Senator Elizabeth Warren has already made the first move. She sent a letter to Commerce Secretary Howard Lutnick questioning the legality of the government's equity stake in Intel. If Democrats win the Senate, Warren is poised to become chair of the Senate Banking Committee, granting her the statutory authority to subpoena witnesses and demand documents.

Henrietta Treyz stated that Democrats "will seize every opportunity to attack the president for as long as possible." She predicts Democratic-led committees will summon corporate executives and government officials to testify on Capitol Hill, which "poses risks to both corporate brands and stock prices, making it one of the most critical concerns for investors right now."

Such political pressure is not without precedent. In 2009, the Bush and Obama administrations faced fierce Republican criticism over the government's stake in General Motors, which helped spawn the Tea Party movement. The key difference today is that the government was then rescuing a company on the brink of bankruptcy, whereas the Trump administration is now actively "picking winners"—this shift in logic could fundamentally change the nature and intensity of any political backlash.

Legal Risk: A Plaintiff Victory Could Undermine the Entire Portfolio

Compared to elections, the legal risks may be even more profound. A shareholder lawsuit currently challenging the legality of the government's stake in Intel could have ripple effects across the entire government shareholding portfolio.

The lawsuit argues that the CHIPS Act does not authorize the government to require equity as a condition for providing subsidies, and accuses Intel's board of breaching fiduciary duties, characterizing the deal as an "extortionate" power grab. Lutnick has moved to dismiss the case, arguing that the arrangement is authorized under federal law and is vital to the U.S. defense industrial base. Intel CEO Lip-Bu Tan and other board members have also filed motions to dismiss.

Josh Lipsky, senior director of the Atlantic Council's GeoEconomics Center, warned: "If a court ultimately rules that the CHIPS Act does not grant the Commerce Department the authority to do what it did with Intel, it would have broad implications for many of these deals." Ann Lipton, a law professor at the University of Colorado, further noted that such a ruling would also cast doubt on the Commerce Department's equity investments in other companies using CHIPS Act funds, including IBM and GlobalFoundries.

Mark Malek, chief investment officer at Siebert Financial, articulated the market's dilemma. His firm holds Intel shares, and he remarked: "It's the government's investment that truly turned things around, and it's a key factor sustaining the stock price. If that factor disappears, what happens next? That's exactly why we haven't increased our position."

Structural Vulnerability: Politically Driven Momentum Eventually Reverts to Fundamentals

Above all these risks lies a more fundamental issue: when the logic driving stock prices is political rather than fundamental, that momentum is inherently fragile.

Gina Martin Adams, chief market strategist at HB Wealth Management, noted that the risks of government "endorsement" are ever-present: "It may have positively influenced the stock price, but that could partly be the result of investors chasing a political trend, which makes the momentum quite fragile." Matt Gertken, head of geopolitical and U.S. political analysis at BCA Research, characterized the current situation as an "interventionist path" that has not yet been fully tested or digested within the U.S. system. "There will be ups and downs in this process," he said.

From a broader perspective, the Trump administration's strategy has upended the traditional logic of government involvement in private enterprise—moving from bailouts to endorsements. This shift has generated impressive short-term stock gains, but it has also sown the seeds of overlapping political, legal, and market risks. As the midterm election countdown begins, investors are reassessing just how far this government-backed trade can really go.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10